SPDR S&P Biotech shares owned by ProVise Management Group
Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by ProVise Management Group
from 13F filings
Historical chart of ProVise Management Group investment in SPDR S&P Biotech
Tip: Access up to 7 years of quarterly data
All positions including SPDR S&P Biotech held by ProVise Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in SPDR S&P Biotech by ProVise Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $458k | 4.6k | 98.80 |
| 2024-06-30 | $402k | 4.3k | 92.71 |
| 2024-03-31 | $411k | 4.3k | 94.89 |
| 2023-12-31 | $322k | 3.6k | 89.29 |
| 2023-09-30 | $296k | 4.1k | 73.02 |
| 2023-06-30 | $309k | 4.1k | 76.21 |
| 2023-03-31 | $309k | 4.1k | 76.21 |
| 2022-12-31 | $336k | 4.1k | 83.00 |
| 2022-09-30 | $321k | 4.1k | 79.24 |
| 2022-06-30 | $301k | 4.1k | 74.30 |
| 2022-03-31 | $274k | 3.1k | 89.81 |
| 2021-12-31 | $398k | 3.6k | 112.08 |
| 2021-09-30 | $446k | 3.6k | 125.60 |
| 2021-06-30 | $481k | 3.6k | 135.45 |
| 2021-03-31 | $583k | 4.3k | 135.68 |
| 2020-12-31 | $542k | 3.8k | 140.85 |
| 2020-09-30 | $473k | 4.2k | 111.43 |
| 2020-06-30 | $377k | 3.4k | 111.80 |
| 2020-03-31 | $228k | 2.9k | 77.50 |